Zhuzhou Qianjin Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhuzhou Qianjin Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
sales of 2.80 billion Chinese Renmimbi [US$413.38 million]
of which 100%
Harbin Gloria Pharmaceuticals Co., Ltd
(2.98 billion Chinese Renmimbi [US$440.85 million]
of which 77%
was Pharmaceutical Manufacturing), and
Jilin Aodong Medicine Industry (Group) Co., Ltd.
(2.74 billion Chinese Renmimbi [US$404.32 million]
of which 97%
was Pharmaceutical Manufacturing).
During the year ended December of 2016, sales at
Zhuzhou Qianjin Pharmaceutical Co., Ltd. were 2.86 billion Chinese Renmimbi (US$423.28 million).
increase of 17.1%
versus 2015, when the company's sales were 2.45 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Zhuzhou Qianjin Pharmaceutical Co., Ltd.
(and since 2011, sales have increased a total of 128%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
35.8% in 2016, from
160.34 million Chinese Renmimbi to 217.67 million Chinese Renmimbi.